Effects of lysophospholipids on the generation of reactive oxygen species by fMLP-and PMA-stimulated human neutrophils

Luminescence

Volumn 17, Issue 3, 2002, Pages 141-149

  Müller, Julia ^a   Petković, Marijana ^a,b   Schiller, Jürgen ^a   Arnold, Klaus ^a   Reichl, Sabine ^a,c   Arnhold, Jürgen ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Luminol amplified chemiluminescence; Lysophospholipids; MALDI TOF mass spectrometry; NADPH oxidase

Indexed keywords

MASS SPECTROMETRY; OXYGEN; PHOSPHOLIPIDS;

HUMAN NEUTROPHIL; LUMINOL-AMPLIFIED CHEMILUMINESCENCE; LUMINOLS; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPIDS; MALDI-TOF MASS SPECTROMETRY; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; STIMULATED CELLS;

CHEMILUMINESCENCE;

FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUMINOL; LYSOPHOSPHOLIPID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

BLOOD; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; KINETICS; LUMINESCENCE; MASS SPECTROMETRY; METABOLISM; NEUTROPHIL; OXIDATION REDUCTION REACTION; PHYSIOLOGY; RESPIRATORY BURST; ARTICLE; CHEMOLUMINESCENCE; DRUG EFFECT;

CELL MEMBRANE; CELL SURVIVAL; ENZYME ACTIVATION; HUMANS; KINETICS; LUMINESCENT MEASUREMENTS; LUMINOL; LYSOPHOSPHOLIPIDS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADPH OXIDASE; NEUTROPHILS; OXIDATION-REDUCTION; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRADECANOYLPHORBOL ACETATE; CHEMILUMINESCENT MEASUREMENTS;

EID: 0036583612     PISSN: 15227235     EISSN: None     Source Type: Journal    
DOI: 10.1002/bio.681     Document Type: Article

References (40)

1. Gaits F, Fourcade O and Le Balle F et al. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 1997; 410: 54-58.
2. Baker RR and Chang HA. A metabolic path for the degradation of lysophosphatidic acid, an inhibitor of lysophosphatidylcholine lysophospholipase, in neuronal nuclei of cerebral cortex. Biochim. Biophys. Acta 2000; 1483: 58-68.
3. Chilton FH and Murphy RC. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. J. Biol. Chem. 1986; 261: 7771-7777.
4. Sugiura T, Mazusawa Y, Nakagawa Y and Waku K. trans-Acylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities. J. Biol. Chem. 1987; 262: 1199-1205.
5. Weltzien HU. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 1979; 559: 259-287.
6. Goetzl EJ and An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 1998; 12: 1589-1598.
7. Ozaki H, Ishii K, Arai H, Kume N and Kita T. Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine-dependent pathway in bovine aortic endothelial cells. Atherosclerosis 1999; 143: 261-266.
8. Sakai M, Miyazaki A and H Kamata H et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidised low density lipoprotein on murine macrophages. J. Biol. Chem. 1994; 269: 31430-31435.
9. Marinetti GV and Cattieu K. Composition of phospholipids of human leukocytes. Chem. Phys. Lipids 1982; 31: 169-177.
10. Portman OW and Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid Res. 1969; 10: 158-165.
11. 31P NMR. J. Lipid Res. 2001; 42: 1501-1508.
12. McMurray HF, Parthasarathy S and Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 1993; 92: 1004-1008.
13. Quinn MT, Parthasarathy S and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl Acad. Sci. USA 1988; 85: 2805-2805.
14. Kume N, Cybulsky MI and Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin. Invest. 1992; 90: 1138-1144.
15. Wong JT, Tran K, Pierce GN, Chan AC, O K and Choy PC. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J. Biol. Chem. 1998; 273: 6830-6836.
16. Gómez-Muñoz A, O'Brien L, Hundal R and Steinbrecher UP. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J. Lipid Res. 1999; 40: 988-993.
17. Fang X, Gibson S, Flowers M, Furui T, Bast Jr. RC and Mills GB. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. J. Biol. Chem. 1997; 272: 13683-13689.
18. Asaoka Y, Oka M, Yoshida K and Nishizuka Y. Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation. Biochem. Biophys. Res. Commun. 1991; 178: 1378-1385.
19. Ginsburg I, Ward PA and Varani J. Lysophosphatides enhance superoxide responses of stimulated human neutrophils. Inflammation 1989; 13: 163-174.
20. Ryborg AK, Deleuran B, Sogaard H and Kragballe K. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Dermatol. Venereol. 2000; 80: 242-246.
21. Zhou D, Luini W and Bernasconi S et al. Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J. Biol. Chem. 1995; 270: 25549-25556.
22. Gerrard J and Robinson P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta 1989; 1001: 282-285.
23. Nietgen GW and Durieux ME. Intercellular signalling by lysophosphatidate. Recent developments. Cell Adhes. Commun. 1998; 5: 221-235.
24. Bøyum A. Separation of white blood cells. Nature 1964; 204: 793-794.
25. Bender JG and Van Epps DE. Analysis of the bimodal chemiluminescence pattern of stimulated neutrophils by chemotactic factors. Infect. Immun. 1983; 41: 1062-1070.
26. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959; 37: 911-917.
27. Schiller J, Arnhold J, Benard S, Müller M, Reichl S and Arnold K. Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: a methodological approach. Anal. Biochem. 1999; 267: 45-56.
28. Hillenkamp F, Karas M, Beavis RC and Chait BT. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal. Chem. 1991; 63: 1193A-1203A.
29. Petković M, Schiller J and Müller M et al. Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal. Biochem. 2001; 289: 202-216.
30. Petković M, Schiller J, Müller J, Müller M, Arnold K and Arnhold J. The signal-to-noise ratio as the measure for the quantification of lysophospholipids by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Analyst 2001; 126: 1042-1050.
31. - generating NADPH oxidase of phagocytes. Structure and methods of detection. Methods: A Companion to Methods in Enzymology 1996; 9: 563-577.
32. Kitagawa T, Inoue K and Nojima S. Properties of liposomal membranes containing lysolecithin. J. Biochem. 1976; 79: 1123-1133.
33. Müller S and Arnhold J. Light emission of luminol and its application. In Chemiluminescence at the Turn of the Millennium - An Indispensable Tool in Modern Chemistry, Biochemistry and Medicine, Albrecht S, Zimmerman T, Brandl H (eds). SchwedaWerbedruck-Verlag: Dresden, 2001; 23-28.
34. Arnhold J, Benard S, Kilian U, Reichl S, Schiller J and Arnold K. Modulation of luminol chemiluminescence of fMet-Leu-Phe-stimulated neutrophils by affecting dephosphorylation and the metabolism of phosphatidic acid. Luminescence 1999; 14: 129-137.
35. McPhail L, Wane KA and Regier DS et al. A novel protein kinase target for the lipid second messenger phosphatidic acid. Biochim. Biophys. Acta 1999; 1439: 277-290.
36. Friedman P, Haimovitz R, Markman O, Roberts MF and Shinitzky M. Conversion of lysophospholipids to cyclic lysophosphatidic acid by phospholipase D. J. Biol. Chem. 1996; 271: 953-957.
37. Moolenaar WH. Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 1995; 7: 203-210.
38. van Corven EJ, Groenink A, Jalink K, Eichholtz T and Moolenaar WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 1989; 59: 45-54.
39. Kodama H, Zhang J and Sugara K. Novel priming of cystathione metabolites on superoxide generation in human neutrophils. Biochem. Biophys. Res. Commun. 2000; 269: 297-301.
40. 2. Curr. Rev. Immunol. 1997; 17: 225-283.